June 30, 2023
A monthslong shortage of chemotherapies forces some patients to receive less treatment. University of Cincinnati Cancer Center's Davendra Sohal told the Wall Street Journal his patients were also impacted.
October 17, 2023
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing patients with access to cutting edge treatments only available through the network.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
September 12, 2022
Two College of Medicine residency programs have both been ranked third in the country for clinical experience
August 15, 2022
Drs Melanie Cushion, Michael Farrell and Bruce Giffin have been named 2022 recipients of Daniel Drake Medals.
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
April 15, 2021
Consumers Affairs reported the findings of a University of Cincinnati study that looked at the relationship between air pollution and the severity of COVID-19 infections in patients who had preexisting respiratory disease. Angelico Mendy, MD, PhD, assistant professor in the UC College of Medicine, was lead author of the study.
April 22, 2021
Taejeong Song, PhD, a postdoctoral fellow in the UC College of Medicine, says a regulatory protein found in skeletal muscle fiber may play an important role in the body’s fight or flight response when encountering dangerous situations.
June 7, 2021
Hanan Kerr, MD, has received a Fulbright U.S. Scholar fellowship and will spend 10 months in Rwanda in 2022 developing a cardiovascular training program.
May 27, 2021
Research from University of Cincinnati cardiologist Dr. Donald Lynch Jr. suggests that plasma proteins discovered in the blood samples of diabetic patients who went on to develop obstructive coronary disease (OCAD) serve as biomarkers of future heart disease. Lynch presented the preliminary findings at the American College of Cardiology.